Correlation Between Pressure Differences and Micro-vascularization Changes in Bedridden Paraplegic Patient (VASCIP)
Primary Purpose
Pressure Ulcer, Bedsore, Spinal Cord Injury
Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Measurement of interface pressure
Measurement of micro-vascularization related parameters
Sponsored by
About this trial
This is an interventional basic science trial for Pressure Ulcer focused on measuring Pressure ulcer, Interface pressure, Pressure mapping device, Monitoring, Microvascularization
Eligibility Criteria
Inclusion Criteria:
- Educated consent signed,
- Older than 18,
- Paraplegia for at least 6 months,
- Surgery planned for pressure ulcer resection,
Exclusion Criteria:
- Dementia,
- Stade IV arteritis non-revascularisable,
- Patient with no health insurance,
- Pregnant women or breast-feeding, patient unable to give his or her educated consent, ward of the state (art. L.1121-6, L.1121-7, L.1211-8, L.1211-9),
- Patient taking part in another study which could impact the local micro-vascularization.
Sites / Locations
- University Regional Hospital Lapeyronie
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
Single arm
Arm Description
Measurement of interface pressure and Measurement of micro-vascularization related parameters
Outcomes
Primary Outcome Measures
Measure of the pressure intensity in one area
Pressure intensity is recorded using a mapping pressure device (XSensor), set up on the patient hospital bed. Hemoglobin quantity is measured the same day, at a precise area identified on the pressure mapping device (peak pressure), using the O2C - a micro-vascularization device. All measure are non-invasive.
Measure of the hemoglobin quantity in the same area
Hemoglobin quantity is measured the same day, at a precise area identified on the pressure mapping device (peak pressure), using the O2C - a micro-vascularization device. All measure are non-invasive.
Secondary Outcome Measures
Measure of other micro-vascularization related parameters (such as the oxygen saturation and the blood flow) recorded at the same area.
All micro-vascularization related parameters are measured the same day, at a precise area identified on the pressure mapping device (peak pressure), using the O2C - a micro-vascularization device. All measure are non-invasive.
Full Information
NCT ID
NCT03114345
First Posted
March 30, 2017
Last Updated
December 8, 2021
Sponsor
University Hospital, Montpellier
Collaborators
Hill-Rom, Institut National de la Santé Et de la Recherche Médicale, France
1. Study Identification
Unique Protocol Identification Number
NCT03114345
Brief Title
Correlation Between Pressure Differences and Micro-vascularization Changes in Bedridden Paraplegic Patient
Acronym
VASCIP
Official Title
Correlation Between Pressure Differences and Micro-vascularization Changes in Bedridden Paraplegic Patient
Study Type
Interventional
2. Study Status
Record Verification Date
December 2021
Overall Recruitment Status
Terminated
Why Stopped
Departure of the PhD in charge of the study
Study Start Date
November 22, 2017 (Actual)
Primary Completion Date
November 22, 2019 (Actual)
Study Completion Date
November 22, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Montpellier
Collaborators
Hill-Rom, Institut National de la Santé Et de la Recherche Médicale, France
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Paraplegic patients have defective wound healing for sore below the level of spinal lesion. Defect of vascularization of the healing zone certainly participate to this effect. Therefore, this study want to measure, in a clinical settings, the interface pressure (e.g. the pressure between the patient body and the surface he/she is lying on) to assess the correlation between mechanical stress in term of pressure applied over time and tissue oxygenation which represent micro-vascular function. The aim of this clinical trial is to correlate the variations of pressure intensities and changes in micro-vascularization. The measure are recorded when paraplegic patient came into the hospital for pressure ulcer related surgery. The patient is laying on his/her mattress on top of a flexible pressure mapping device. The micro-vascularization parameters are measured at the area displaying the peak pressure a few minutes after the beginning of the pressure interface recording and one hour later at the same area. The data generated during this monocentric study will help to achieve a better understanding of the relation between pressure and micro-vascularization. In the mid term, it will provide a better and more patient adapted pressure ulcer prevention.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pressure Ulcer, Bedsore, Spinal Cord Injury, Paraplegia
Keywords
Pressure ulcer, Interface pressure, Pressure mapping device, Monitoring, Microvascularization
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
4 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Single arm
Arm Type
Other
Arm Description
Measurement of interface pressure and Measurement of micro-vascularization related parameters
Intervention Type
Other
Intervention Name(s)
Measurement of interface pressure
Intervention Description
A capacitive pressure mapping device (XSensor) is set up on the patient air mattress bed. It records the interface pressure on the whole patient body with one frame every second during one hour. Then the file is saved and the pressure mapping device is removed from the patient hospital bedroom.
Intervention Type
Other
Intervention Name(s)
Measurement of micro-vascularization related parameters
Intervention Description
A medical device called O2C, measuring micro-vascularization related parameters (oxygen saturation, hemoglobin quantity and blood flow) is used. The probe (= an optic fibre) is set up lightly on the patient skin or on a transparent adhesive for 1 minute. The median value of the local micro-vascularization parameters are saved on the O2C interface. The location of the measurement is chosen using the pressure mapping device to locate peak pressure area. Then the O2C is removed from the patient hospital bedroom.
Primary Outcome Measure Information:
Title
Measure of the pressure intensity in one area
Description
Pressure intensity is recorded using a mapping pressure device (XSensor), set up on the patient hospital bed. Hemoglobin quantity is measured the same day, at a precise area identified on the pressure mapping device (peak pressure), using the O2C - a micro-vascularization device. All measure are non-invasive.
Time Frame
Measurements are done the same date as the inclusion, during the patient hospitalization for his/her pressure ulcer related surgery.
Title
Measure of the hemoglobin quantity in the same area
Description
Hemoglobin quantity is measured the same day, at a precise area identified on the pressure mapping device (peak pressure), using the O2C - a micro-vascularization device. All measure are non-invasive.
Time Frame
Measurements are done the same date as the inclusion, during the patient hospitalization for his/her pressure ulcer related surgery.
Secondary Outcome Measure Information:
Title
Measure of other micro-vascularization related parameters (such as the oxygen saturation and the blood flow) recorded at the same area.
Description
All micro-vascularization related parameters are measured the same day, at a precise area identified on the pressure mapping device (peak pressure), using the O2C - a micro-vascularization device. All measure are non-invasive.
Time Frame
Measurements are done the same date as the inclusion, during the patient hospitalization for his/her pressure ulcer related surgery.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Educated consent signed,
Older than 18,
Paraplegia for at least 6 months,
Surgery planned for pressure ulcer resection,
Exclusion Criteria:
Dementia,
Stade IV arteritis non-revascularisable,
Patient with no health insurance,
Pregnant women or breast-feeding, patient unable to give his or her educated consent, ward of the state (art. L.1121-6, L.1121-7, L.1211-8, L.1211-9),
Patient taking part in another study which could impact the local micro-vascularization.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stefan Matecki, M.D.
Organizational Affiliation
CHU de Montpellier
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Regional Hospital Lapeyronie
City
Montpellier
State/Province
Languedoc-Roussillon
ZIP/Postal Code
34295
Country
France
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Correlation Between Pressure Differences and Micro-vascularization Changes in Bedridden Paraplegic Patient
We'll reach out to this number within 24 hrs